This interactive presentation outlines strategies for the co-management of medical cannabis and opioids in patients with chronic pain.
PROGRAM LEARNING OBJECTIVES
At the conclusion of the learning activity, participants will be better able to:
1. Describe the impact of the opioid crisis and opioid-related harm
2. Discuss the rationale of using medical cannabis as an adjunctive treatment with opioids
3. Initiate medical cannabis in a patient on opioids
4. Taper opioid doses in patients who respond to medical cannabis
Speaker: Celeste Begrand, MN RN NP
Date: March 30, 2021
Time: 6:00 pm CST (Saskatchewan)/ 7:00 pm CDT (Manitoba) / 8:00 pm EDT (Ontario)
All attendees will receive a $50 credit towards dinner upon completion of the program and evaluation form.